BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22050419)

  • 21. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
    Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
    Leukemia; 2006 May; 20(5):820-6. PubMed ID: 16541142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
    Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid resistance in childhood leukemia.
    Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
    Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    McNeer JL; Nachman JB
    Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    Meyer LK; Delgado-Martin C; Maude SL; Shannon KM; Teachey DT; Hermiston ML
    PLoS One; 2019; 14(7):e0220026. PubMed ID: 31318944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential network analysis and protein-protein interaction study reveals active protein modules in glucocorticoid resistance for infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Rahmatallah Y; Masoudi-Nejad A
    Mol Med; 2019 Aug; 25(1):36. PubMed ID: 31370801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia.
    Styczyński J; Wysocki M
    Haematologia (Budap); 2002; 32(4):313-25. PubMed ID: 12803106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
    Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia.
    Soh SX; Lim JY; Huang JW; Jiang N; Yeoh AE; Ong ST
    PLoS One; 2014; 9(8):e103435. PubMed ID: 25090024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia.
    Ploner C; Rainer J; Niederegger H; Eduardoff M; Villunger A; Geley S; Kofler R
    Leukemia; 2008 Feb; 22(2):370-7. PubMed ID: 18046449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
    High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
    Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
    Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
    Leuk Res; 2007 Sep; 31(9):1293-301. PubMed ID: 17306873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of AP-1 in glucocorticoid resistance in leukaemia.
    Bailey S; Hall AG; Pearson AD; Redfern CP
    Leukemia; 2001 Mar; 15(3):391-7. PubMed ID: 11237062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Pieters R
    Leukemia; 2003 Jan; 17(1):17-25. PubMed ID: 12529655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
    Yan J; Jiang N; Huang G; Tay JL; Lin B; Bi C; Koh GS; Li Z; Tan J; Chung TH; Lu Y; Ariffin H; Kham SK; Yeoh AE; Chng WJ
    Br J Haematol; 2013 Oct; 163(1):93-103. PubMed ID: 23888996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.
    Toscan CE; Jing D; Mayoh C; Lock RB
    Br J Cancer; 2020 Jun; 122(12):1769-1781. PubMed ID: 32242100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.